Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Norhammar

Showing results (41-50 of 106) with videos related to

Pageof 11
Sort By:
Diabetes & Vascular Disease Research|January 26, 2017
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohortMaria Isabel Smaradottir, Viveca Ritsinger, Viveca Gyberg, et al.
Diabetes & Vascular Disease Research|July 12, 2018
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohortViveca Ritsinger, Kerstin Brismar, Linda Mellbin, et al.
International Endodontic Journal|September 25, 2021
Endodontic inflammatory disease: A risk indicator for a first myocardial infarctionDan Sebring, Kåre Buhlin, Anna Norhammar, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty studyCamilla Hage, Anna Norhammar, Lars Grip, et al.
Diabetes Care|September 30, 2003
Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetesAke Tenerz, Anna Norhammar, Angela Silveira, et al.
Diabetes & Vascular Disease Research|October 15, 2014
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohortViveca Ritsinger, Eleni Tanoglidi, Klas Malmberg, et al.
BMJ Open|May 12, 2023
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort studyMargret Leosdottir, Emil Hagstrom, Nermin Hadziosmanovic, et al.
Diabetes Care|February 22, 2018
Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry ReportViveca Ritsinger, Christel Hero, Ann-Marie Svensson, et al.
Cardiovascular Diabetology|January 13, 2024
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic statesAlessia Riccio, Elena Fortin, Linda Mellbin, et al.
Pharmacoeconomics - Open|April 7, 2018
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014David Nathanson, Ugne Sabale, Jan W Eriksson, et al.
Pageof 11

Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
Diabetes & Vascular Disease Research|January 26, 2017
Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohortMaria Isabel Smaradottir, Viveca Ritsinger, Viveca Gyberg, et al.
Diabetes & Vascular Disease Research|July 12, 2018
Elevated levels of insulin-like growth factor-binding protein 1 predict outcome after acute myocardial infarction: A long-term follow-up of the glucose tolerance in patients with acute myocardial infarction (GAMI) cohortViveca Ritsinger, Kerstin Brismar, Linda Mellbin, et al.
International Endodontic Journal|September 25, 2021
Endodontic inflammatory disease: A risk indicator for a first myocardial infarctionDan Sebring, Kåre Buhlin, Anna Norhammar, et al.
Diabetes & Vascular Disease Research|April 7, 2010
Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty studyCamilla Hage, Anna Norhammar, Lars Grip, et al.
Diabetes Care|September 30, 2003
Diabetes, insulin resistance, and the metabolic syndrome in patients with acute myocardial infarction without previously known diabetesAke Tenerz, Anna Norhammar, Angela Silveira, et al.
Diabetes & Vascular Disease Research|October 15, 2014
Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohortViveca Ritsinger, Eleni Tanoglidi, Klas Malmberg, et al.
BMJ Open|May 12, 2023
Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort studyMargret Leosdottir, Emil Hagstrom, Nermin Hadziosmanovic, et al.
Diabetes Care|February 22, 2018
Characteristics and Prognosis in Women and Men With Type 1 Diabetes Undergoing Coronary Angiography: A Nationwide Registry ReportViveca Ritsinger, Christel Hero, Ann-Marie Svensson, et al.
Cardiovascular Diabetology|January 13, 2024
Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic statesAlessia Riccio, Elena Fortin, Linda Mellbin, et al.
Pharmacoeconomics - Open|April 7, 2018
Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014David Nathanson, Ugne Sabale, Jan W Eriksson, et al.
Pageof 11